We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

35 hedge funds and large institutions have $3.7M invested in Perspective Therapeutics in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.05% less ownership

Funds ownership: 1.18% → 1.13% (-0.05%)

19% less funds holding

Funds holding: 43 → 35 (-8)

29% less capital invested

Capital invested by funds: $5.19M → $3.7M (-$1.49M)

77% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 13

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

Holders
35
Holders Change
-8
Holders Change %
-18.6%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WE
Wealth Effects
Massachusetts
+$34.2K
2
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$342
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$48

Top Sellers

Rank Fund Capital Flow
1
VCM
Venator Capital Management
Ontario, Canada
-$170K
2
PCM
Perkins Capital Management
Minnesota
-$21.8K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$11K
4
TSS
Two Sigma Securities
New York
-$10K
5
VF
Virtu Financial
New York
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.39M – – –
PCM
2
Perkins Capital Management
Minnesota
$655K -$21.8K -6,386 -2%
BlackRock
3
BlackRock
New York
$562K -$687 -201 -0.1%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$260K – – –
TMWM
5
Taylor & Morgan Wealth Management
Michigan
$177K -$1.71K -500 -0.6%
BA
6
Bard Associates
Illinois
$154K -$513 -150 -0.2%
State Street
7
State Street
Massachusetts
$127K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$86K -$1.7K -496 -1%
Northern Trust
9
Northern Trust
Illinois
$56K – – –
BCM
10
Bridgeway Capital Management
Texas
$42K – – –
Creative Planning
11
Creative Planning
Kansas
$30K – – –
WE
12
Wealth Effects
Massachusetts
$25K +$34.2K +10,000 +1,000%
Morgan Stanley
13
Morgan Stanley
New York
$19K -$10 -3 -0%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$18K – – –
CAG
15
Crestwood Advisors Group
Massachusetts
$13K – – –
Two Sigma Advisers
16
Two Sigma Advisers
New York
$10K -$3.39K -990 -18%
Cerity Partners
17
Cerity Partners
New York
$9K – – –
WWA
18
WCG Wealth Advisors
Nevada
$8K – – –
BBNA
19
Bremer Bank National Association
Minnesota
$7K – – –
Citadel Advisors
20
Citadel Advisors
Florida
$6K -$5.17K -1,511 -37%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$6K +$48 +14 +0.6%
Commonwealth Equity Services
22
Commonwealth Equity Services
Massachusetts
$6K +$342 +100 +4%
Millennium Management
23
Millennium Management
New York
$5K -$5.24K -1,531 -41%
TWM
24
TMD Wealth Management
Arizona
$5K – – –
Victory Capital Management
25
Victory Capital Management
Texas
$4K -$1.36K -398 -20%
1
2

CATX Hedge Fund Activity: Q3 2022 in Review

35 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2022, worth a combined $3.7M — down 29% from $5.19M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of CATX and 0 opened new positions — a net loss of 8 holders — while 13 trimmed existing stakes and 3 added.

The largest buyer was Wealth Effects, adding an estimated $34.2K. The largest seller was Venator Capital Management, exiting entirely with an estimated $170K sold.

  • 35 institutional investors held Perspective Therapeutics (CATX) as of Q3 2022, down from 43 in Q2 2022.
  • Funds reported $3.7M of Perspective Therapeutics stock for Q3 2022, down 29% quarter-over-quarter.
  • 0 funds opened new Perspective Therapeutics positions in Q3 2022 and 8 closed out, a net change of -8 holders.
  • The largest Perspective Therapeutics buyer in Q3 2022 was Wealth Effects, an estimated $34.2K added.
  • The largest Perspective Therapeutics seller in Q3 2022 was Venator Capital Management, an estimated $170K sold.

Based on aggregated 13F filings for Q3 2022.